+$65M
DONATED
169
speakers
7200
attendees
220
partnerships
Sohn Hearts & Minds brings together international thought leaders, research scientists, fund managers, surprise guests and entertainers, in support of Australian medical research, for a one-day annual conference.
More than 600 senior representatives and key decision-makers from over 450 organisations will gather to hear unique insights. Attendees include ultra-high-net worth investors and the Chief Investment Officers of some of Australia’s leading industry and retail super funds, representing more than $500 billion of wholesale funds under management.
For the first time in its seven-year history, Sohn Hearts & Minds will partner with the South Australian Government to deliver the conference in Adelaide. Attendees will experience the best of South Australia all while raising vital funds to build medical research capabilities across the nation.
"Delegates and guests will be able to see for themselves, the innovative ecosystem we have across key sectors of growth, including critical technologies; health and medical; energy and mining; defence and space; food, wine and agribusiness and tourism. The conference will give a significant boost to health and medical research in South Australia, donating 50 per cent of the funds raised to be used right here in our state."
Nick Champion MP, Minister for Trade and Investment.
The 2023 Sohn Hearts & Minds Conference, featured speakers such as famed hedge fund manager Dan Loeb from New York-based Third Point; Dr Peter Attia, world-leading longevity expert and founder of Early Medical; Professor Misty Jenkins AO, WEHI and Cathie Wood of ARK Invest.
Sohn Hearts & Minds is on track to raise more than $60 million for medical research through conference ticket sales and donated fees from its listed investment company, known as Hearts and Minds Investments (ASX: HM1).
In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated nearly $70 million to medical research.
The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”
Howard Marks says investors must ignore manic depressive markets and focus on the bigger picture. Rates will be higher for longer and that will bring pain – and opportunity.
For billionaire investor and Oaktree Capital co-founder Howard Marks there’s little point in predicting whether the sharemarket is in bubble territory or where the market goes from here. That’s the enemy of long-term investment.
